Interdisciplinary radiation medicine for nonmalignant diseases: featuring coronary/vascular restenosisWAKSMAN, Ron.International journal of radiation oncology, biology, physics. 1996, Vol 36, Num 4, issn 0360-3016, 236 p.Serial Issue

Drug-eluting stent safetyPINTO SLOTTOW, Tina L; WAKSMAN, Ron.The American journal of cardiology. 2007, Vol 100, Num 8B, issn 0002-9149, 10M-17M, SUPArticle

Current state of the absorbable metallic (magnesium) stentWAKSMAN, Ron.EuroIntervention. 2009, Vol 5, issn 1774-024X, F94-F97, SUPFArticle

Features and parameters of drug-eluting stent deployment discoverable by intravascular ultrasoundMINTZ, Gary S.The American journal of cardiology. 2007, Vol 100, Num 8B, issn 0002-9149, 26M-35M, SUPArticle

Definition, Incidence, Correlates, and Clinical Impact of Nuisance Bleeding in Patients Undergoing Drug-Eluting Stent ImplantationWAKSMAN, Ron.The American journal of cardiology. 2009, Vol 104, Num 5, issn 0002-9149, 30C-33C, SUPArticle

Overview of the 2011 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee Meeting on the Edwards SAPIEN™ Transcatheter Heart ValveBARBASH, Israel M; WAKSMAN, Ron.Circulation (New York, N.Y.). 2012, Vol 125, Num 3, pp 550-555, issn 0009-7322, 6 p.Article

Therapeutic potential of oral antiproliferative agents in the prevention of coronary restenosisKUCHULAKANTI, Pramod; WAKSMAN, Ron.Drugs (Basel). 2004, Vol 64, Num 21, pp 2379-2388, issn 0012-6667, 10 p.Article

Proton Pump inhibitors and ClopidogrelGAGLIA, Michael A; WAKSMAN, Ron.Cardiovascular therapeutics (Print). 2010, Vol 28, Num 3, pp 169-176, issn 1755-5914, 8 p.Article

Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel Meeting on the Xience V Everolimus-Eluting Coronary StentTORGUSON, Rebecca; WAKSMAN, Ron.The American journal of cardiology. 2008, Vol 102, Num 12, pp 1624-1630, issn 0002-9149, 7 p.Article

Cypher versus taxus: all smoke and no fire : Lessons for future comparative drug-eluting stent trials in interventional cardiologyBUCH, Ashesh N; WAKSMAN, Ron.The American journal of cardiology. 2007, Vol 99, Num 3, pp 424-427, issn 0002-9149, 4 p.Article

Clinical practice of radiotherapy and oncology in India : Past and present statusGUPTA, B. D.International journal of radiation oncology, biology, physics. 1996, Vol 36, Num 4, pp 945-947, issn 0360-3016Article

Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stentWAKSMAN, Ron; PAKALA, Rajbabu.EuroIntervention. 2009, Vol 5, issn 1774-024X, F36-F42, SUPFArticle

Edge Effect From Drug-Eluting Stents as Assessed With Serial Intravascular Ultrasound: A Systematic ReviewWAKABAYASHI, Kohei; WAKSMAN, Ron; WEISSMAN, Neil J et al.Circulation. Cardiovascular interventions. 2012, Vol 5, Num 2, pp 305-311, issn 1941-7640, 7 p.Article

Biodegradable and Bioabsorbable StentsWAKSMAN, Ron; PAKALA, Rajbabu.Current pharmaceutical design (Print). 2010, Vol 16, Num 36, pp 4041-4051, issn 1381-6128, 11 p.Article

Serial imaging and histology illustrating the degradation of a bioabsorbable magnesium stent in a porcine coronary arteryPINTO SLOTTOW, Tina L; PAKALA, Rajbabu; WAKSMAN, Ron et al.European heart journal. 2008, Vol 29, Num 3, pp 314-314, issn 0195-668X, 1 p.Article

Endovascular β-irradiation after percutaneous transluminal coronary balloon angioplastyPOPOWSKI, Y; VERIN, V; URBAN, P et al.International journal of radiation oncology, biology, physics. 1996, Vol 36, Num 4, pp 841-845, issn 0360-3016Article

Management of peripheral vascular disease : Innovative approaches using radiation therapyNORI, D; PARIKH, S; MONI, J et al.International journal of radiation oncology, biology, physics. 1996, Vol 36, Num 4, pp 847-856, issn 0360-3016Article

Overview of the 2013 Food and Drug Administration Circulatory System Devices Panel Meeting on the MitraClip Delivery SystemMINHA, Sa'ar; TORGUSON, Rebecca; WAKSMAN, Ron et al.Circulation (New York, N.Y.). 2013, Vol 128, Num 8, pp 864-868, issn 0009-7322, 5 p.Article

Hypothermia Therapy: Neurological and Cardiac BenefitsDELHAYE, Cedric; MAHMOUDI, Michael; WAKSMAN, Ron et al.Journal of the American College of Cardiology. 2012, Vol 59, Num 3, pp 197-210, issn 0735-1097, 14 p.Article

The dose distribution produced by a ³²P source for endovascular irradiationXU, Z; ALMOND, P. R; DEASY, J. O et al.International journal of radiation oncology, biology, physics. 1996, Vol 36, Num 4, pp 933-939, issn 0360-3016Article

Engineering a bioresorbable stent: REVA programme updatePOLLMAN, Matthew J.EuroIntervention. 2009, Vol 5, issn 1774-024X, F54-F57, SUPFArticle

Overview of the 2007 food and drug administration circulatory system devices panel meeting on patent foramen ovale closure devicesPINTO SLOTTOW, Tina L; STEINBERG, Daniel H; WAKSMAN, Ron et al.Circulation (New York, N.Y.). 2007, Vol 116, Num 6, pp 677-682, issn 0009-7322, 6 p.Article

Peripheral vascular brachytherapySIDAWY, Anton N; WEISWASSER, Jonathan M; WAKSMAN, Ron et al.Journal of vascular surgery. 2002, Vol 35, Num 5, pp 1041-1047, issn 0741-5214Conference Paper

Bioabsorbable polymers in medicine: an overviewVERT, Michel.EuroIntervention. 2009, Vol 5, issn 1774-024X, F9-F14, SUPFArticle

Antiplatelet therapy after implantation of drug-eluting stents : Duration, resistance, alternatives, and management of surgical patientsGURBEL, Paul A; DICHIARA, Joseph; TANTRY, Udaya S et al.The American journal of cardiology. 2007, Vol 100, Num 8B, issn 0002-9149, 18M-25M, SUPArticle